| A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®) (NCT05070663) | Sanofi | 2021-11-04 |
| A Feasibility Study of SenseGuard to Assess Airway Responsiveness During Methacholine Challenge Test (MCT) (NCT05149885) | NanoVation | 2021-11-04 |
| The Alberta BLOOM Premature Child Study (NCT05011071) | University of Calgary | 2021-10-21 |
| Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma (NCT04987944) | Pfizer | 2021-10-18 |
| Innate Immunity in Allergic Asthma (NCT06068335) | University of Central Florida | 2021-10-18 |
| A Trial of SHR-1703 in Asthma (NCT05042401) | Jiangsu HengRui Medicine Co., Ltd. | 2021-10-12 |
| Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres (NCT05932849) | AstraZeneca | 2021-10-05 |
| Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers (NCT05085587) | Respirent Pharmaceuticals Co Ltd. | 2021-10-01 |
| Qualitative Assessment of Patients Suffering From Difficult Asthma (NCT05185375) | University Hospital, Montpellier | 2021-10-01 |
| Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers (NCT03567694) | Conjupro Biotherapeutics, Inc. | 2021-10-01 |
| Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes (NCT03885245) | University of Colorado, Denver | 2021-10-01 |
| Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device (NCT05145894) | Healthy Networks | 2021-09-30 |
| EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients (NCT04998604) | Sanofi | 2021-09-27 |
| Acoustic Cough Monitoring for the Management of Patients With Known Respiratory Disease (NCT05042063) | Clinica Universidad de Navarra, Universidad de Navarra | 2021-09-15 |
| Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma (NCT04946318) | Novartis Pharmaceuticals | 2021-09-08 |
| Investigating Dupilumab's Effect in Asthma by Genotype (NCT03694158) | Boston Children's Hospital | 2021-09-08 |
| First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 (NCT04993443) | Syneos Health | 2021-09-06 |
| The Clinical Value of the Nitric Oxide System Components in Asthma and COPD (NCT04456491) | Ryazan State Medical University | 2021-09-01 |
| Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Mepolizumab (SASAM Study) (NCT05040997) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-09-01 |
| Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With or Without Nasal Polyps (NCT05009758) | Medical University of Vienna | 2021-09-01 |
| Telecounselling for Asthma Counseling (NCT05021796) | National University Health System, Singapore | 2021-09-01 |
| Finding Correlations Between Asthma Exacerbation, Physiological Measurements and Environmental Factors (NCT04845932) | North Carolina State University | 2021-09-01 |
| ENCOMPASS: Expansion Study C (NCT04791267) | University of Calgary | 2021-08-17 |
| A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions (NCT05021887) | Respirent Pharmaceuticals Co Ltd. | 2021-08-13 |
| Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma (NCT04937387) | GlaxoSmithKline | 2021-07-29 |
| A Trial of SHR-1905 in Healthy Subjects (NCT04800263) | Atridia Pty Ltd. | 2021-07-27 |
| Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents (NCT04748055) | University of North Carolina, Chapel Hill | 2021-07-27 |
| Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics (NCT04933383) | Aquilon Pharmaceuticals S.A. | 2021-07-23 |
| Evaluation of the Effect of Web-designed Training Developed for Asthma Patients (NCT04607681) | Eskisehir Osmangazi University | 2021-07-21 |
| Teva Asthma Predictive Analytics Study (NCT04997304) | University of Michigan | 2021-07-09 |
| Residual Exacerbations With Mepolizumab (NCT04578171) | Laval University | 2021-07-06 |
| Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma (NCT04276233) | GlaxoSmithKline | 2021-06-29 |
| Effect of Electronic Monitoring and Feedback on Adherence to Easyhaler Controller Medication in Patients With Asthma (NCT04869384) | Orion Corporation, Orion Pharma | 2021-06-23 |
| Breathing Retraining for Asthma Trial of Home Exercises for Teenagers (NCT05006703) | University of Southampton | 2021-06-22 |
| Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma (NCT04706988) | Chinese University of Hong Kong | 2021-06-22 |
| A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes (NCT04902573) | Chiesi UK | 2021-06-17 |
| Biomarkers of Chronic Obstructive Pulmonary Disease (NCT04963023) | Centre Hospitalier Universitaire, Amiens | 2021-06-15 |
| A Trial of SHR-1703 in Healthy Subjects (NCT04855591) | Atridia Pty Ltd. | 2021-06-14 |
| Educational Intervention for Asthmatic and Allergic Patients (NCT04928638) | Universidad de Granada | 2021-06-12 |
| Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma (NCT04589663) | Novartis Pharmaceuticals | 2021-06-07 |
| Benralizumab Initiated During Severe Asthma Attack (NCT04617171) | Singapore General Hospital | 2021-06-02 |
| Cardiorespiratory Diagnostic Study (NCT04939558) | TidalSense | 2021-06-02 |
| Short Treatment with Omalizumab for Severe Asthma (NCT04763447) | Assistance Publique - Hôpitaux de Paris | 2021-05-20 |
| Exacerbation Risk in Asthma (NCT05501639) | Boehringer Ingelheim | 2021-05-14 |
| To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years. (NCT04848662) | Bond Avillion 2 Development LP | 2021-05-06 |
| A Study to Test if TEV-53275 is Effective in Relieving Asthma (NCT04847674) | Teva Branded Pharmaceutical Products R&D, Inc. | 2021-05-04 |
| ASTHMAXcel Emergency Department Study (NCT05013073) | Montefiore Medical Center | 2021-05-01 |
| MANI Real-life Perspective Observatory (NCT04796844) | Societa Italiana di Pneumologia | 2021-05-01 |
| Monitoring Metered Dose Inhalation (MDI) Volume and Timing With a Respimetrix Device in Obstructive Lung Disease. (NCT05495256) | Pulmonary Critical Care Associates of Baltimore | 2021-05-01 |
| AdditioN of Fixed Dose Combination (FDC) Of Budesonide/Formoterol Via Elpenhaler® Device in Greek Patients With asThma accΟrding to Standard Clinical Practice. (NCT04835961) | Elpen Pharmaceutical Co. Inc. | 2021-05-01 |
| Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (NCT05169619) | AstraZeneca | 2021-04-30 |
| Pulmonary Inflammation and Microbiome Changes With Bariatric Surgery in Obese Asthma (NCT04247971) | Duke University | 2021-04-30 |
| Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform (NCT04868500) | AstraZeneca | 2021-04-27 |
| Wheeze Detection Using Aevice Medical Device (NCT05194436) | Aevice Health Pte. Ltd. | 2021-04-23 |
| AIM2ACT: A Mobile Health Tool to Help Adolescents Self-Manage Asthma (NCT04448002) | University of Florida | 2021-04-23 |
| US PRECISION Implementation Study (NCT04891978) | AstraZeneca | 2021-04-20 |
| Single Ascending Dose Study of CM326 in Healthy Volunteers (NCT04842201) | Keymed Biosciences Co.Ltd | 2021-04-13 |
| The Effects of Endurance and Strength Training in Subjects With Asthma (NCT04935125) | Istituti Clinici Scientifici Maugeri SpA | 2021-04-13 |
| Gut Microbiota in Chronic Noncommunicable Diseases (NCT04820556) | National Medical Research Center for Therapy and Preventive Medicine | 2021-04-12 |
| Combined Neuromuscular Electrical Stimulation for Quadriceps and Triceps During Pulmonary Rehabilitation in COPD (NCT04684966) | University Hospital, Brest | 2021-04-08 |
| Similarities and Differences of Biological Therapies for Severe Asthma. (NCT04665141) | Clinica Universidad de Navarra, Universidad de Navarra | 2021-04-07 |
| The Feasibility of Asthma Application of Mobile Phone and Mobile Spirometry for Home Monitor of Asthma Patients (NCT04808089) | Chang Gung Memorial Hospital | 2021-04-02 |
| Remote Monitoring of Respiratory Health (NCT04739943) | Stanford University | 2021-04-01 |
| Effect of Mepolizumab on Severe Eosinophilic Asthma (NCT04641741) | Hospital Clinico Universitario de Santiago | 2021-04-01 |
| Oxidative Stress in Asthma (NCT04512547) | Bastiaan Driehuys | 2021-04-01 |
| Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) (NCT04098718) | University of Oxford | 2021-03-29 |
| Serum Potassium Prediction Using Machine Learning and Single-lead ECG (NCT07493798) | Brigham and Women's Hospital | 2021-03-20 |
| Prediction of Expected Length of Hospital Stay Using Machine Learning (NCT04784351) | Brigham and Women's Hospital | 2021-03-20 |
| Prediction of Patient Deterioration Using Machine Learning (NCT05045742) | Brigham and Women's Hospital | 2021-03-20 |
| Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype (NCT04719832) | GlaxoSmithKline | 2021-03-17 |
| Comparative Effectiveness of Telemedicine in Primary Care (NCT04684836) | Weill Medical College of Cornell University | 2021-03-15 |
| Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids (NCT04643158) | AstraZeneca | 2021-03-12 |
| Analysis of Sexual Bias in Type 2 Innate Lymphoid Cells (ILC2) in Asthmatic Patients (NCT04384835) | University Hospital, Toulouse | 2021-03-08 |
| Appropriate Inhaler Use of Tiotropium As Add-on Therapy in Symptomatic Asthma (NCT04696965) | Chang Gung Memorial Hospital | 2021-03-04 |
| An Electronic Shared Decision-Making Application to Improve Asthma Outcomes (NCT04951102) | University of Michigan | 2021-03-03 |
| Novel Inflammatory Markers in Different Phenotypes of Severe Asthma (NCT04888910) | University of Pisa | 2021-03-01 |
| To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong (NCT04639791) | Chinese University of Hong Kong | 2021-03-01 |
| A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects (NCT04772365) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-03-01 |
| Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS) (NCT04609904) | AstraZeneca | 2021-03-01 |
| Implementing, a Mobile Health Application for HIV Infected and Uninfected Women With Co-morbidities in the Outpatient Setting (NCT04810260) | Montefiore Medical Center | 2021-03-01 |
| ENCOMPASS: Expansion Study B, RCT (NCT04790617) | University of Calgary | 2021-03-01 |
| Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study (NCT04991805) | AstraZeneca | 2021-02-26 |
| Study on Patterns of Care in Mild Asthmatic Patients (NCT04598555) | Chiesi Farmaceutici S.p.A. | 2021-02-25 |
| Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma (NCT04927195) | Evelo Biosciences, Inc. | 2021-02-23 |
| Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma (NCT04673630) | AstraZeneca | 2021-02-23 |
| Rural Home Hospital: Proof of Concept (NCT04531280) | Brigham and Women's Hospital | 2021-02-18 |
| A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma (NCT04677959) | Teva Branded Pharmaceutical Products R&D, Inc. | 2021-02-16 |
| Is Asthma in Subjects With Obstructive Sleep Apnoea (OSA) Due to Dysanapsis (NCT04142905) | Norfolk and Norwich University Hospitals NHS Foundation Trust | 2021-02-10 |
| The Effect of Physiotherapy on Dysfunctional Breathing in Children and Adolescents With and Without Asthma (NCT04728191) | Kolding Sygehus | 2021-02-10 |
| The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma (NCT04734795) | Kolding Sygehus | 2021-02-05 |
| Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study (NCT04724278) | National Jewish Health | 2021-02-05 |
| A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype (NCT04718103) | GlaxoSmithKline | 2021-02-04 |
| Impact of COVID19 on Asthma Patients in Spain (NCT05064501) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2021-02-01 |
| A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype (NCT04718389) | GlaxoSmithKline | 2021-01-26 |
| ENCOMPASS: Expansion Study A, RCT (NCT04790604) | University of Calgary | 2021-01-22 |
| A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers (NCT04746040) | Respirent Pharmaceuticals Co Ltd. | 2021-01-18 |
| Perspectives and Management of Atypical Asthma (NCT04932551) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-01-15 |
| Utilizing CT Based Imaging Parameters of Body Composition to Understand Heterogeneity of Response to Biologic Therapies in Severe Asthma Cohorts (NCT06922760) | University of Michigan | 2021-01-15 |
| Creation of Home-based Asthma Real-World Measures With Mobile Health Study (NCT04462224) | National Jewish Health | 2021-01-11 |
| SELF-BREATHE RCT for Chronic Breathlessness (NCT04574050) | King's College Hospital NHS Trust | 2021-01-11 |